kesimpta
novartis ireland ltd - ofatumumab - heila-og mænusigg, köstum tilkynnt - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.
regkirona
celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - Ónæmiskerfið sera og mótefni, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
risperdal filmuhúðuð tafla 1 mg
janssen-cilag ab - risperidonum inn - filmuhúðuð tafla - 1 mg
dostinex tafla 0,5 mg
pfizer aps - cabergolinum inn - tafla - 0,5 mg
mykofenolatmofetil actavis filmuhúðuð tafla 500 mg
actavis group ptc ehf. - mycophenolatum mofetil - filmuhúðuð tafla - 500 mg
rivotril tafla 0,5 mg
cheplapharm arzneimittel gmbh - clonazepamum inn - tafla - 0,5 mg
rivotril tafla 2 mg
cheplapharm arzneimittel gmbh - clonazepamum inn - tafla - 2 mg